A

Calliditas Therapeutics Launches an Online Patient Platform

Retrieved on: 
Saturday, May 14, 2022 - 1:00pm

STOCKHOLM, Sweden, May 14, 2022 (GLOBE NEWSWIRE) -- Calliditas Therapeutics AB (Nasdaq: CALT, Nasdaq Stockholm: CALTX) (Calliditas) today announced the launch of IgAN Connect, a new online platform to provide resources to people living with IgA nephropathy, or IgAN, a chronic autoimmune disease.

Key Points: 
  • STOCKHOLM, Sweden, May 14, 2022 (GLOBE NEWSWIRE) -- Calliditas Therapeutics AB (Nasdaq: CALT, Nasdaq Stockholm: CALTX) (Calliditas) today announced the launch of IgAN Connect, a new online platform to provide resources to people living with IgA nephropathy, or IgAN, a chronic autoimmune disease.
  • Bonnie Schneider, Director and Co-Founder of the IgA Nephropathy Foundation of America commented, IgA nephropathy is a complicated disease that can leave individuals with many unanswered questions.
  • With the launch of IgAN Connect, I am grateful that individuals will have even more resources to embark on this journey.
  • Calliditas common shares are listed on Nasdaq Stockholm (ticker: CALTX) and its American Depositary Shares are listed on the Nasdaq Global Select Market (ticker: CALT).

"Houses For Sale Near Me" Real Estate Marketing Tech Platform Keeps It Simple With 1 Form, No Hassles

Retrieved on: 
Wednesday, May 11, 2022 - 7:45pm

LOS ANGELES, May 11, 2022 /PRNewswire-PRWeb/ -- HousesForSaleNearMe.com™ launches a new technologically advanced marketing technology platform and consumer facing website aimed at capturing a small percentage of the millions of monthly online searches for the keywords "houses for sale near me" and connecting those consumers with real estate professionals, with as little hassle as possible. "One form, no hassles, and you're connected to a real estate professional in your area," per the website.

Key Points: 
  • Houses For Sale Near Me real estate marketing technology platform seeks to connect the millions of consumers searching for "Houses For Sale Near Me" keywords per month with the real estate professionals by keeping it simple with just one form.
  • "One form, no hassles, and you're connected to a real estate professional in your area," per the website.
  • Strictly a marketing technology platform, and not a real estate agency or brokerage, the Houses For Sale Near Me website only connects residential buyers, sellers, renters and real estate professionals, without participating in any manner in the advisement of the consumer, or in the real estate transaction.
  • Residential Real Estate buyers sellers, renters and real estate professionals can explore if simple is better at HousesForSaleNearMe.com .

Global Driving Apparel Market Report to 2027 - Featuring Fox Head, ThorMX and Scott Sports Among Others - ResearchAndMarkets.com

Retrieved on: 
Wednesday, May 11, 2022 - 10:43am

The "Global Driving Apparel Market Size & Share to 2027" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Driving Apparel Market Size & Share to 2027" report has been added to ResearchAndMarkets.com's offering.
  • Increase in awareness regarding road safety norms and enforcement of stringent government regulation for driving across the world is considered as key driving factor which is expected to boost the global driving apparel market growth.
  • However, availability of substitute products at lower prices is the major challenging factor which is expected to hamper the global driving apparel market growth.
  • Also, Global Driving Apparel Market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.

First Korean Astronaut Dr. Soyeon Yi & First Korean American Female Napa Winemaker Cecil Park Release a Commemorative Wine to Inspire a New Generation to Reach for the Stars

Retrieved on: 
Wednesday, April 20, 2022 - 2:00pm

Dr. Yi inspired award-winning winemaker Cecil Park, founder of Winefornia , to create the 2018 Soyeon, Cabernet Sauvignon from Rutherford, Napa.

Key Points: 
  • Dr. Yi inspired award-winning winemaker Cecil Park, founder of Winefornia , to create the 2018 Soyeon, Cabernet Sauvignon from Rutherford, Napa.
  • Astronaut Dr. Yi and winemaker Cecil Park are sharing their inspirational stories as women-minority entrepreneurs in the traditionally male-dominated field of space, business, and winemaking.
  • Through the launch of this wine, I hope to share my story as a Korean astronaut and invite the next generation to explore different fields, said Dr. Soyeon Yi.
  • We are the first Korean astronaut and the first Korean American Napa winemaker, and we want to make sure we are not the last, Park said.

OPPO Becomes First Smartphone Brand to Light Up Ain Dubai, World's Largest and Tallest Observation Wheel in Celebration of Reno7 Series Launch

Retrieved on: 
Tuesday, March 15, 2022 - 8:07pm

DUBAI, March 15, 2022 /PRNewswire/ -- Global technology brand OPPO has launched the all-new Reno7 Series in the GCC region offering customers 'Unlimited Me, In Portrait'. The series goes from strength to strength allowing novices to create professional looking photos and images in three models: the Reno7 Pro 5G, Reno7 5G and Reno7 Z 5G. 

Key Points: 
  • The series goes from strength to strength allowing novices to create professional looking photos and images in three models: the Reno7 Pro 5G , Reno7 5G and Reno7 Z 5G .
  • To celebrate the launch, OPPO became the first smartphone brand to unveil a light show on Ain Dubai, the world's largest and tallest observation wheel.
  • Since the launch of the first OPPO Reno smartphone, Reno users worldwide have been capturing the world around them in stunning, professional-quality portraits.
  • This has included the launch of its flagship OPPO Find X Series and the introduction of the OPPO Reno Series.

OPPO Becomes First Smartphone Brand to Light Up Ain Dubai, World's Largest and Tallest Observation Wheel in Celebration of Reno7 Series Launch

Retrieved on: 
Tuesday, March 15, 2022 - 8:04pm

The series goes from strength to strength allowing novices to create professional looking photos and images in three models: the Reno7 Pro 5G , Reno7 5G and Reno7 Z 5G .

Key Points: 
  • The series goes from strength to strength allowing novices to create professional looking photos and images in three models: the Reno7 Pro 5G , Reno7 5G and Reno7 Z 5G .
  • To celebrate the launch, OPPO became the first smartphone brand to unveil a light show on Ain Dubai, the world's largest and tallest observation wheel.
  • Since the launch of the first OPPO Reno smartphone, Reno users worldwide have been capturing the world around them in stunning, professional-quality portraits.
  • This has included the launch of its flagship OPPO Find X Series and the introduction of the OPPO Reno Series.

Philadelphia Insurance Companies Selects Duck Creek Technologies OnDemand to Launch New Offering for Small Commercial

Retrieved on: 
Tuesday, March 15, 2022 - 12:30pm

Philadelphia Insurance Companies is preparing to enter a new line to enhance their US commercial business offerings in 2023.

Key Points: 
  • Philadelphia Insurance Companies is preparing to enter a new line to enhance their US commercial business offerings in 2023.
  • After a careful review of market-ready solutions, they chose Duck Creek OnDemand for its scalability, extensibility, and ease to launch commercial lines products using templated, low-code configurations.
  • Duck Creek also offered PHLY a digital-first approach via Duck Creek Producer to optimize customer experience and enhance existing distribution channels.
  • I have long admired Philadelphia Insurance Companies and their mission to deliver innovative products to niche insurance markets, said Michael Jackowski, CEO of Duck Creek Technologies.

Everest Medicines Enters into Agreement with Calliditas Therapeutics, Expanding Territory License to Develop and Commercialize NEFECON in South Korea

Retrieved on: 
Monday, March 14, 2022 - 12:00am

SHANGHAI, March 13, 2022 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK), a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products to address critical unmet needs in Asia Pacific markets, announced today that it has entered into a license agreement with Calliditas Therapeutics AB (Nasdaq: CALT, Nasdaq Stockholm: CALTX) to develop and commercialize NEFECON for the treatment of primary IgA nephropathy (IgAN) in South Korea, expanding its license in addition to rights held in Greater China and Singapore. The deal signals the Company's latest efforts to further enhance its international commercial footprint.

Key Points: 
  • "South Korea's sophisticated healthcare model enables innovative medicines such as NEFECON to have a higher potential likelihood of healthcare coverage once approved.
  • Under the terms of the agreement, Calliditas receives an initial upfront payment of USD$3 million at signing of the agreement.
  • In June 2019, Everest Medicines entered into an exclusive, royalty-bearing license agreement with Calliditas, which gives Everest Medicines exclusive rights to develop and commercialize NEFECON in Mainland China, Hong Kong, Macau, Taiwan and Singapore.
  • The agreement was extended in March 2022 to include South Korea as part of Everest Medicine's territories.

Salubris Biotherapeutics Announces $32 Million Financing to Advance Novel Complex Biologics for Cardiovascular, Oncology, and Neurodegenerative Diseases

Retrieved on: 
Monday, March 7, 2022 - 12:00pm

Salubris Biotherapeutics, Inc. (SalubrisBio), a clinical-stage biotechnology company dedicated to discovering and developing novel complex biologic therapeutics, today announced it received $32 million in financing from China-based Shenzhen Salubris Pharmaceuticals Co., Ltd.

Key Points: 
  • Salubris Biotherapeutics, Inc. (SalubrisBio), a clinical-stage biotechnology company dedicated to discovering and developing novel complex biologic therapeutics, today announced it received $32 million in financing from China-based Shenzhen Salubris Pharmaceuticals Co., Ltd.
  • We are focused on advancing our programs and securing additional funding to progress the development of our portfolio of antibody fusion proteins and other complex biologics.
  • Since its inception, SalubrisBio has built a drug discovery and development platform to address significant unmet medical needs in cardiovascular diseases, cancer and neurodegenerative diseases.
  • SalubrisBio is a clinical-stage biotechnology company dedicated to discovering and developing complex biologics for cardiovascular, oncology, and neurodegenerative diseases.

Microbix Announces Issuance of Stock Options

Retrieved on: 
Thursday, February 24, 2022 - 12:00pm

MISSISSAUGA, Ontario, Feb. 24, 2022 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix), a life sciences innovator and exporter, announces the issuance of stock options under its shareholder-approved 2018 stock option plan (the Stock Option Plan), as part of its compensation programs to incentivize and retain its board of directors, executives, and managers.

Key Points: 
  • MISSISSAUGA, Ontario, Feb. 24, 2022 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix), a life sciences innovator and exporter, announces the issuance of stock options under its shareholder-approved 2018 stock option plan (the Stock Option Plan), as part of its compensation programs to incentivize and retain its board of directors, executives, and managers.
  • In consultation with the CEO, CFO, and COO, Microbixs Board of Directors has approved the issuance of 2,805,000 options in accordance with the terms of the Stock Option Plan.
  • Management believes that stock options are an important tool to incentivize and retain senior personnel, particularly for smaller, publicly-listed companies.
  • In February 2019, Microbix announced its intention to broadly use its stock option plan once per year following the issuance of its Q1 results.